NCT04370834 2025-02-04Tocilizumab for Patients With Cancer and COVID-19 DiseaseNational Cancer Institute (NCI)Phase 2 Terminated1 enrolled 10 charts
NCT01326728 2018-06-06Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell TransplantationNational Institutes of Health Clinical Center (CC)Terminated56 enrolled 12 charts
NCT00089089 2013-01-07Decitabine in Treating Patients With Advanced Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Terminated42 enrolled